Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 14/20 | 0.72 |
| ▸ | LPL | P06858 | 13/20 | 0.72 |
| ▸ | P4HB | P07237 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.39 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | F11 | P03951 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23750178 | 0.98 | LIPG (0.76) | LIPGLPLP4HBDGAT1PDGFRB | |
| SCHEMBL868327 | 0.96 | LIPG (0.72) | LIPGLPLP4HBDGAT1PDGFRB | |
| SCHEMBL19106675 | 0.96 | LIPG (0.72) | LIPGLPLP4HBDGAT1PDGFRB | |
| SCHEMBL19106678 | 0.96 | LIPG (0.72) | LIPGLPLP4HBDGAT1PDGFRB | |
| SCHEMBL12619964 | 0.95 | LIPG (0.66) | LIPGLPLP4HBDGAT1PDGFRB | |
| SCHEMBL20088883 | 0.94 | LIPG (0.76) | LIPGLPLP4HBDGAT1PDGFRB | |
| SCHEMBL17726029 | 0.94 | LIPG (0.76) | LIPGLPLP4HBDGAT1PDGFRB | |
| SCHEMBL17177868 | 0.94 | LIPG (0.76) | LIPGLPLP4HBDGAT1PDGFRB | |
| SCHEMBL20088879 | 0.93 | LIPG (0.68) | LIPGLPLP4HBDGAT1PDGFRB | |
| SCHEMBL18134363 | 0.93 | LIPG (0.68) | LIPGLPLP4HBDGAT1PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220416172-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-12-29 | — | — | US | disclosed |
| US-11512076-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-11-29 | — | — | US | disclosed |
| US-20200172524-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2020-06-04 | — | — | US | disclosed |
| US-9469616-B2 | Cyclic compounds and methods of making and using the same | CELLCEUTIX CORPORATION (US) | 2016-10-18 | — | — | US | disclosed |
| US-20150031738-A1 | CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | UNIVERSITY OF MASSACHUSETTS (US) | 2015-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220416172-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | NDUFS5, KCNJ2, EHMT2 | LIPG 3001/4885LPL 3380/4885P4HB 2705/4885 |
| US-11512076-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | PIEZO1, OCIAD1, LEF1 | LIPG 1174/4885LPL 3024/4885P4HB 2018/4885 |
| US-20150031738-A1 | CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | MUC1, TLR3, ALG1 | LIPG 2456/4885LPL 2572/4885P4HB 1302/4885 |
| US-20200172524-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | LIPG 1174/4885LPL 3024/4885P4HB 2018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.